VIP943

· Vincerx Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VIP943, covering 2024-11-15 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies [Phase 1]